Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households

NCT03969212 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4138

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: Baloxavir Marboxil
DRUG: Placebo

Sponsor

Hoffmann-La Roche